The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab.

NCT07212062 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

NETWORK

Sponsor class

Conditions

Alzheimers Disease

Interventions

DRUG: X/T + X-EC
DRUG: Placebo
DRUG: Lecanemab 10 mg/kg

Sponsor

Neurology Office of South Florida

Collaborators

[object Object]